Company Performance Metrics
David Tran: President
Ronald C. Griffith: Director and Chief Science OfficerPast Role: Genelabs Technologies, Chief Scientific Officer
OUR DEVELOPMENT, PASSION AND UNWAVERING COMMITMENT IN THE FIGHT AGAINST VIRAL AND ALZHEIMER’S DISEASE
LuTran Inc. is a dynamic, innovation–driven pharmaceutical research company located in the heart of Silicon Valley, where we push the boundaries of medical science to discover and develop novel medicines for some of the world's most
debilitating viral and neurological diseases: from AIDS through biosafety level 4 viruses, including Ebola hemorrhagic fever and Alzheimer’s.
OUR MISSION STATEMENT IS OUR CONSTITUTION, VISION AND VALUES
Our mission is to develop novel, more effective medicines through scientific innovation, to ultimately live in a world where humankind regardless of their geographic region or social status, can live free from infectious viral diseases and Alzheimer’s.
CONTINUOUS TRANSFORMATION IS KEY TO OUR INNOVATIVE RESEARCH
Our innovation is the result of our passion, commitment and pushing the limits of our understanding by exploring new ideas to accelerate the discovery, development and delivery of next–generation medications. We celebrate curiosity and encourage our researchers to take chances in discovering novel solutions to increase longevity and improve quality of life for millions of people around the world.
STAYING COMMITTED TO OUR DISCOVERIES WITH ONGOING FLEXIBILITY IN FINDING NOVEL SOLUTIONS
Innovation doesn't just stop with the development of new technologies or creating a new kind of compound. We believe scientific innovation, especially in the medical field, should be linked with the human experience. Therefore, any new idea, any innovation needs to be developed and utilized in a way with a positive impact on the lives of patients around the globe.
